Displaying 13 - 16 of 16

Display:

12 24 48

Immune-Mediated and Cholestatic Diseases

7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View

Displaying 13 - 16 of 16

Display:

12 24 48